A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC
Ontology highlight
ABSTRACT: The purpose of this study to assess efficacy and tolerability of combination therapy FOLFOXIRI with Bevacizumab (BV) as a first-line therapy in patients with metastatic colorectal cancer.
DISEASE(S): Colorectal Neoplasms
PROVIDER: 2174842 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA